<?xml version="1.0" encoding="UTF-8"?>
<p id="p0280">Once a generic framework that could be applied to vaccine R&amp;D broadly was established, the working group undertook a series of meetings applying the process map to three case studies of different vaccine candidates under development for three of the UKVN’s priority pathogens: MERS Viral Vector vaccine, Zika protein subunit/VLP vaccine (
 <xref rid="f0015" ref-type="fig">Fig. 3</xref> ), and the Prokarium Vaxonella® Plague vaccine (
 <xref rid="f0020" ref-type="fig">Fig. 4</xref> ). The case studies can be accessed through the main landing page of the process map 
 <xref rid="fn2" ref-type="fn">2</xref>.
</p>
